EDTA-chelation treatment
Collet, J.T.
Nederlands Tijdschrift Voor Geneeskunde 136(4): 191-192
1992
ISSN/ISBN: 0028-2162 PMID: 1736133 Document Number: 398995
Document emailed within 1 workday
Related Documents
Feddersen, S.; Flytlie, K.T.; Hancke, C. 1997: EDTA chelation--a medical treatment and a surgical problem Ugeskrift for Laeger 159(21): 3196-3197Chappell, L.T. 1995: EDTA chelation therapy should be more commonly used in the treatment of vascular disease Alternative Therapies in Health and Medicine 1(2): 53-57
Daghustani, M.; Alhammadi, A.; Merdad, K.; Ohlin, J.; Erhardt, F.; Ahlquist, M. 2011: Comparison between high concentration EDTA (24%) and low concentration EDTA (3%) with surfactant upon removal of smear layer after rotary instrumentation: a SEM study Swedish Dental Journal 35(1): 9-15
Broyer, M. 1989: Kidney transplantation in children--data from the EDTA registry. The EDTA Registry Committee Transplantation Proceedings 21(1 Pt 2): 1985-1988
O'Brien, S.F.; Kelly, S.E.; Dolphin, P.J.; Russell, J.C. 2000: Chelation therapy in the JCR:LA-cp rat: experimental assessment of a putative antiatherosclerotic treatment Clinical and Investigative Medicine 23(2): 124-131
Margolis, S. 1995: Chelation therapy is ineffective for the treatment of peripheral vascular disease Alternative Therapies in Health and Medicine 1(2): 53-56
Kosanke, J. 2012: EDTA glycine acid treatment of red blood cells Immunohematology 28(3): 95-96
Guldager, B.; Brixen, K.T.; Jørgensen, S.J.; Nielsen, H.K.; Mosekilde, L.; Jelnes, R. 1993: Effects of intravenous EDTA treatment on serum parathyroid hormone (1-84) and biochemical markers of bone turnover Danish Medical Bulletin 40(5): 627-630
Wooley, R.E.; Schall, W.D.; Eagon, R.G.; Scott, T.A. 1974: Efficacy of EDTA-tris-lysozyme lavage in the treatment of experimentally in induced Pseudomonas aeruginosa cystitis in the dog American Journal of Veterinary Research 35(1): 27-29
Spanò, C.; La Licata, R. 1972: Conversion to positivity of false negative latex/hepatitis associated antigen agglutination test upon treatment of sera with edta or trypsin Zeitschrift für Immunitatsforschung Experimentelle und Klinische Immunologie 144(4): 396-399
Pippard, M.J. 1988: Iron chelation in thalassemia Birth Defects Original Article Series 23(5b): 35-40
Geller, S.L. 1986: Questions on chelation therapy Journal of the Florida Medical Association 73(12): 921-922
De Montalembert, M.; Guillemot, F.; Clairicia, M.; Girot, R. 1989: Iron chelation in children Annales de Pediatrie 36(8): 533-538
Soffer, A. 1975: Chelation therapy for arteriosclerosis JAMA 233(11): 1206-1207
Kontoghiorghes, G.J. 1992: Advances in oral iron chelation in man International Journal of Hematology 55(1): 27-38
Godfrey, M.E.; Frackleton, J.P.; Chappell, L.T. 1994: Chelation therapy for intermittent claudication New Zealand Medical Journal 107(990): 495
Peter, H.H. 1983: Iron chelation. Biological significance and medical application Schweizerische Medizinische Wochenschrift 113(40): 1428-1433
Callea, F. 1998: Iron chelation with oral deferiprone in patients with thalassemia New England Journal of Medicine 339(23): 1710-1711; Author Reply 1713-1714
Malatesta, V.; Morazzoni, F.; Gervasini, A.; Arcamone, F. 1985: Chelation of copper(II) ions by doxorubicin and 4'-epidoxorubicin: an e.s.r. study Anti-Cancer Drug Design 1(1): 53-57
Giardina, P.J.; Grady, R.W. 2001: Chelation therapy in beta-thalassemia: an optimistic update Seminars in Hematology 38(4): 360-366